Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Overcoming cellular multidrug resistance using classical nanomedicine formulations.

Overcoming cellular multidrug resistance using classical nanomedicine formulations. Eur J Pharm Sci. 2012 Mar 12; 45(4):421-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.